Jeffrey Geyer
Vice President, Investor Relations
Replay available
Molina Healthcare Inc (NYSE: MOH) Q3 2025 earnings conference call, held 2025-10-23. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Analyst, Barclays
Analyst, Wells Fargo
Analyst, UBS
Analyst, Nefron Research
Analyst, Wolf Research
Analyst, Bank of America
Analyst, TD Cowen
Analyst, Morgan Stanley
Analyst, Bernstein
Analyst, Deutsche Bank
Analyst, Baird
Analyst, Guggenheim
Analyst, JP Morgan
Analyst, Goldman Sachs
Good morning and welcome to Molina Healthcare's third quarter 2025 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Jeffrey Geyer, Vice President, Investor Relations at Molina Healthcare. Please go ahead. Good morning, and welcome to the Molina Healthcare's third quarter 2025 earnings call. Joining me today are Molina's President and CEO, Joe Zabreski, and our CFO, Mark Keim. A press release announcing our third quarter 2025 earnings was distributed after the market closed yesterday and is available on our investor relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listened to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, October 23rd, 2025, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the third quarter 2025 earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, Statements regarding our 2025 guidance, our preliminary 2026 outlook, the medical cost trend and our projected MCRs, Medicaid rate adjustments and updates, our ...